SAM, Platinum, Simpson Thacher act on KKR 54% acquisition of JB Chemicals for Rs 3,100 crore

SAM, Platinum, Simpson Thacher act on KKR 54% acquisition of JB Chemicals for Rs 3,100 crore
JB Chemicals, KKR

US private equity giant KKR is acquiring about 54 per cent stake in Mumbai-based drug manufacturer JB Chemicals & Pharmaceuticals, one of the oldest pharma companies in India, for Rs 3,100 crore.

Subscribe now to get unlimited access

We're glad you're enjoying Bar and Bench - Indian Legal news . Login and subscribe to continue reading this story.

Already a user? Login

Related Stories

Bar and Bench - Indian Legal news
www.barandbench.com